Yara M. Machlah
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Outcome Of First-Line Chemotherapy For Anaplastic Thyroid Cancer - A Multicenter Registry Analysis.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 14, 2026
ALK Inhibition Prolongs Survival in a Mouse Model of ALK-Positive Anaplastic Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: December 30, 2025
Anaplastic thyroid cancer: Cases, incidence, prevalence and survival in Germany.
Journal: Endocrine
Published: December 19, 2025
Primary Angiosarcomas of the Thyroid: New Insights Into the Genetic Background and Potentially Targetable Therapeutic Markers of an Ultrarare Disease.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 08, 2025
Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTC.
Journal: Endocrine-related cancer
Published: November 07, 2025
Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral Center.
Journal: European journal of endocrinology
Published: July 18, 2025
Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral Center.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 06, 2025
Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties.
Journal: Cell reports. Medicine
Published: August 12, 2024
Systemic therapies for advanced thyroid cancer - an update
Journal: Laryngo- rhino- otologie
Published: February 12, 2024
Precision medicine in endocrinology exemplified by medullary thyroid cancer
Journal: Innere Medizin (Heidelberg, Germany)
Published: November 16, 2023
Systemic therapies for advanced thyroid cancer - an update
Journal: Deutsche medizinische Wochenschrift (1946)
Published: November 02, 2023
Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression.
Journal: Frontiers in immunology
Published: February 28, 2020
Last Updated: 09/26/2026